Kundapur woman dies of A (H1N1) influenza in Mangaluru hospital

Madikeri, Jan 5: Frequent attacks by Tigers on their cattle in South Kodagu region has left the dairy farmers a worried lot and causing concern for their life.

Several farmers have been rearing cows to supplement their income when low prices of pepper and coffee affect their earnings. At least 13 cows have fallen prey to Tigers in the months of November and December last year.

The Forest Department provides a compensation of Rs 10,000 if a cattle is killed by a tiger or in the attack. The compensation amount is meagre when it comes to the loss incurred by the farmers.

Though the Forest Department has submitted a proposal to increase the compensation amount to the government, no action has been initiated in this regard.

Bengaluru, Jul 8: 15 police personnel from Bangalore's Whitefield division tested positive for COVID-19 on Wednesday.

Out of these, 12 are from the Hindustan Aeronautics Limited (HAL) police station, sources said.

A total of 27 police staff of the Whitefield division have tested positive so far and five have been discharged. The HAL police station closed on June 27 after one police staff tested COVID positive. All personnel of the police station were tested in the following days and 12 tests returned positive.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.